Company Name:FibroGen Inc
CEO: Thomas B. Neff

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: FibroGen Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs.


Key numbers

Market Capitalization:3869537500
Shares Outstanding: 87250000
Float: 77145316
Next Earning Date:2020-02-26
TTm EPS: 0.4901
TTm Dividend Rate:
200 days moving average:42.67
50 days moving average: 42.65
One day percent Change: -0.54



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,